Achieving LDL-C levels <55 mg/dL may benefit patients and lesions with lipid-rich plaque phenotypes identified by NIRS imaging.
Does achieving LDL-C levels <55 mg/dL reduce cardiac events in patients with NIRS-derived lipid-rich plaque?
NIRS-derived lipid-rich plaque imaging may help identify patients who would benefit most from aggressive LDL-C lowering to <55 mg/dL.
Absolute Event Rate: 0% vs 0%
NIRS-derived lipid-rich plaque may be a potential imaging measure reflecting patients and lesions that may benefit from achieving LDL-C levels<55mg/dL.
Kataoka et al. (Fri,) reported a other. Achieving LDL-C levels <55 mg/dL may benefit patients and lesions with lipid-rich plaque phenotypes identified by NIRS imaging.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: